These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 21797823)
1. Microsomal prostaglandin E synthase-1 exhibits one-third-of-the-sites reactivity. He S; Wu Y; Yu D; Lai L Biochem J; 2011 Nov; 440(1):13-21. PubMed ID: 21797823 [TBL] [Abstract][Full Text] [Related]
2. Molecular docking and competitive binding study discovered different binding modes of microsomal prostaglandin E synthase-1 inhibitors. He S; Lai L J Chem Inf Model; 2011 Dec; 51(12):3254-61. PubMed ID: 22077876 [TBL] [Abstract][Full Text] [Related]
3. Understanding microscopic binding of human microsomal prostaglandin E synthase-1 with substrates and inhibitors by molecular modeling and dynamics simulation. Hamza A; Abdulhameed MD; Zhan CG J Phys Chem B; 2008 Jun; 112(24):7320-9. PubMed ID: 18476739 [TBL] [Abstract][Full Text] [Related]
4. Understanding microscopic binding of human microsomal prostaglandin E synthase-1 (mPGES-1) trimer with substrate PGH2 and cofactor GSH: insights from computational alanine scanning and site-directed mutagenesis. Hamza A; Tong M; AbdulHameed MD; Liu J; Goren AC; Tai HH; Zhan CG J Phys Chem B; 2010 Apr; 114(16):5605-16. PubMed ID: 20369883 [TBL] [Abstract][Full Text] [Related]
5. Homo-timeric structural model of human microsomal prostaglandin E synthase-1 and characterization of its substrate/inhibitor binding interactions. Xing L; Kurumbail RG; Frazier RB; Davies MS; Fujiwara H; Weinberg RA; Gierse JK; Caspers N; Carter JS; McDonald JJ; Moore WM; Vazquez ML J Comput Aided Mol Des; 2009 Jan; 23(1):13-24. PubMed ID: 18777160 [TBL] [Abstract][Full Text] [Related]
6. Human microsomal prostaglandin E synthase-1 (mPGES-1) binding with inhibitors and the quantitative structure-activity correlation. AbdulHameed MD; Hamza A; Liu J; Huang X; Zhan CG J Chem Inf Model; 2008 Jan; 48(1):179-85. PubMed ID: 18052142 [TBL] [Abstract][Full Text] [Related]
7. PGH2 degradation pathway catalyzed by GSH-heme complex bound microsomal prostaglandin E2 synthase type 2: the first example of a dual-function enzyme. Yamada T; Takusagawa F Biochemistry; 2007 Jul; 46(28):8414-24. PubMed ID: 17585783 [TBL] [Abstract][Full Text] [Related]
8. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin. Schaible AM; Traber H; Temml V; Noha SM; Filosa R; Peduto A; Weinigel C; Barz D; Schuster D; Werz O Biochem Pharmacol; 2013 Aug; 86(4):476-86. PubMed ID: 23623753 [TBL] [Abstract][Full Text] [Related]
9. Murine mPGES-1 3D structure elucidation and inhibitors binding mode predictions by homology modeling and site-directed mutagenesis. Corso G; Coletta I; Ombrato R J Chem Inf Model; 2013 Jul; 53(7):1804-17. PubMed ID: 23789712 [TBL] [Abstract][Full Text] [Related]
10. Discovery of highly potent microsomal prostaglandin e2 synthase 1 inhibitors using the active conformation structural model and virtual screen. He S; Li C; Liu Y; Lai L J Med Chem; 2013 Apr; 56(8):3296-309. PubMed ID: 23527738 [TBL] [Abstract][Full Text] [Related]
11. Nonacidic inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1) identified by a multistep virtual screening protocol. Rörsch F; Wobst I; Zettl H; Schubert-Zsilavecz M; Grösch S; Geisslinger G; Schneider G; Proschak E J Med Chem; 2010 Jan; 53(2):911-5. PubMed ID: 20025212 [TBL] [Abstract][Full Text] [Related]
12. Crystal structure and possible catalytic mechanism of microsomal prostaglandin E synthase type 2 (mPGES-2). Yamada T; Komoto J; Watanabe K; Ohmiya Y; Takusagawa F J Mol Biol; 2005 May; 348(5):1163-76. PubMed ID: 15854652 [TBL] [Abstract][Full Text] [Related]
13. Fragment-based discovery of novel and selective mPGES-1 inhibitors Part 1: identification of sulfonamido-1,2,3-triazole-4,5-dicarboxylic acid. Lee K; Pham VC; Choi MJ; Kim KJ; Lee KT; Han SG; Yu YG; Lee JY Bioorg Med Chem Lett; 2013 Jan; 23(1):75-80. PubMed ID: 23218602 [TBL] [Abstract][Full Text] [Related]
14. Structural and functional characterization of human microsomal prostaglandin E synthase-1 by computational modeling and site-directed mutagenesis. Huang X; Yan W; Gao D; Tong M; Tai HH; Zhan CG Bioorg Med Chem; 2006 May; 14(10):3553-62. PubMed ID: 16439136 [TBL] [Abstract][Full Text] [Related]
16. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor. Mbalaviele G; Pauley AM; Shaffer AF; Zweifel BS; Mathialagan S; Mnich SJ; Nemirovskiy OV; Carter J; Gierse JK; Wang JL; Vazquez ML; Moore WM; Masferrer JL Biochem Pharmacol; 2010 May; 79(10):1445-54. PubMed ID: 20067770 [TBL] [Abstract][Full Text] [Related]
17. Characterization of microsomal prostaglandin E synthase 1 inhibitors. Korotkova M; Jakobsson PJ Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):64-9. PubMed ID: 24138533 [TBL] [Abstract][Full Text] [Related]
18. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation. Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979 [TBL] [Abstract][Full Text] [Related]
19. A dynamic Asp-Arg interaction is essential for catalysis in microsomal prostaglandin E2 synthase. Brock JS; Hamberg M; Balagunaseelan N; Goodman M; Morgenstern R; Strandback E; Samuelsson B; Rinaldo-Matthis A; Haeggström JZ Proc Natl Acad Sci U S A; 2016 Jan; 113(4):972-7. PubMed ID: 26755582 [TBL] [Abstract][Full Text] [Related]
20. Identification of novel mPGES-1 inhibitors through screening of a chemical library. Park SJ; Han SG; Ahsan HM; Lee K; Lee JY; Shin JS; Lee KT; Kang NS; Yu YG Bioorg Med Chem Lett; 2012 Dec; 22(24):7335-9. PubMed ID: 23147075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]